{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:10:58Z","timestamp":1762143058901,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Sun Chieh Yeh Heart Foundation of Hong Kong","award":["3502Z20150050"],"award-info":[{"award-number":["3502Z20150050"]}]},{"name":"Department of Xiamen Science and Technology","award":["15YJ23"],"award-info":[{"award-number":["15YJ23"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.ejphar.2019.03.029","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:11:56Z","timestamp":1552608716000},"page":"74-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells"],"prefix":"10.1016","volume":"853","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Jun","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Yin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Sheng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.03.029_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1536\/ihj.54.240","article-title":"Storms of ventricular fibrillation responsive to isoproterenol in an idiopathic ventricular fibrillation patient demonstrating complete right bundle branch block","volume":"54","author":"Aizawa","year":"2013","journal-title":"Int. Heart J."},{"key":"10.1016\/j.ejphar.2019.03.029_bib2","doi-asserted-by":"crossref","first-page":"H602","DOI":"10.1152\/ajpheart.00673.2003","article-title":"Phenotypic differences in transient outward K+ current of human and canine ventricular myocytes: insights into molecular composition of ventricular Ito","volume":"286","author":"Akar","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1540-8167.2001.00268.x","article-title":"The Brugada syndrome: ionic basis and arrhythmia mechanisms","volume":"12","author":"Antzelevitch","year":"2001","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2015.06.002","article-title":"Brugada syndrome: clinical, genetic, molecular, cellular, and ionic aspects","volume":"41","author":"Antzelevitch","year":"2016","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib5","doi-asserted-by":"crossref","first-page":"e295","DOI":"10.1016\/j.hrthm.2016.05.024","article-title":"J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge","volume":"13","author":"Antzelevitch","year":"2016","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2019.03.029_bib6","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.CIR.0000143159.30585.90","article-title":"Efficacy of quinidine in high-risk patients with Brugada syndrome","volume":"110","author":"Belhassen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.03.029_bib7","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCEP.115.003109","article-title":"Management of brugada syndrome: thirty-three-year experience using electrophysiologically guided therapy with class 1A antiarrhythmic drugs","volume":"8","author":"Belhassen","year":"2015","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.15420\/aer.2018.21.2","article-title":"Pharmacological therapy in brugada syndrome","volume":"7","author":"Brodie","year":"2018","journal-title":"Arrhyth Electrophysiol. Rev."},{"key":"10.1016\/j.ejphar.2019.03.029_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.97.5.457","article-title":"Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease","volume":"97","author":"Brugada","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.03.029_bib10","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/sj.bjp.0705199","article-title":"Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines","volume":"138","author":"Caballero","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0014-2999(99)00368-4","article-title":"Carvedilol blocks the repolarizing K+ currents and the L-type Ca2+ current in rabbit ventricular myocytes","volume":"376","author":"Cheng","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCEP.107.748103","article-title":"Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome","volume":"1","author":"Delpon","year":"2008","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.lfs.2006.10.012","article-title":"Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes","volume":"80","author":"Deng","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2019.03.029_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.amjcard.2013.10.020","article-title":"Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting","volume":"113","author":"DiNicolantonio","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/erc.11.166","article-title":"Carvedilol: a third-generation beta-blocker should be a first-choice beta-blocker","volume":"10","author":"DiNicolantonio","year":"2012","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2019.03.029_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/eci.12696","article-title":"Carvedilol and antioxidant proteins in a type I diabetes animal model","volume":"47","author":"Diogo","year":"2017","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2019.03.029_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.RES.79.4.659","article-title":"Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current","volume":"79","author":"Dixon","year":"1996","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2019.03.029_bib18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurjhf\/hfr020","article-title":"Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial","volume":"13","author":"Dungen","year":"2011","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.ejphar.2019.03.029_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0014-2999(98)00326-4","article-title":"Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model","volume":"351","author":"Feuerstein","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2147\/VHRM.S3148","article-title":"Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction","volume":"4","author":"Frishman","year":"2008","journal-title":"Vasc. Health Risk Manag"},{"key":"10.1016\/j.ejphar.2019.03.029_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/humu.22058","article-title":"Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death","volume":"33","author":"Giudicessi","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejphar.2019.03.029_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCEP.113.000919","article-title":"Cellular mechanism underlying hypothermia-induced ventricular tachycardia\/ventricular fibrillation in the setting of early repolarization and the protective effect of quinidine, cilostazol, and milrinone","volume":"7","author":"Gurabi","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib23","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.hrthm.2011.12.006","article-title":"A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents","volume":"9","author":"Hu","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2019.03.029_bib24","doi-asserted-by":"crossref","first-page":"H704","DOI":"10.1152\/ajpheart.1987.253.3.H704","article-title":"Quinidine-induced inhibition of transient outward current in cardiac muscle","volume":"253","author":"Imaizumi","year":"1987","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bcp.2011.11.019","article-title":"Carvedilol blocks the cloned cardiac Kv1.5 channels in a beta-adrenergic receptor-independent manner","volume":"83","author":"Jeong","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.13679","article-title":"Clemizole hydrochloride blocks cardiac potassium currents stably expressed in HEK 293 cells","volume":"174","author":"Jie","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0008-6363(00)00265-0","article-title":"Antiarrhythmic drug carvedilol inhibits HERG potassium channels","volume":"49","author":"Karle","year":"2001","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.ejphar.2019.03.029_bib28","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yjmcc.2013.12.012","article-title":"Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome","volume":"68","author":"Koncz","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib30","first-page":"307","article-title":"Use of carvedilol in hypertension: an update","volume":"8","author":"Leonetti","year":"2012","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2019.03.029_bib31","doi-asserted-by":"crossref","first-page":"H369","DOI":"10.1152\/ajpheart.1998.275.2.H369","article-title":"Transmural heterogeneity of action potentials and Ito1 in myocytes isolated from the human right ventricle","volume":"275","author":"Li","year":"1998","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib32","doi-asserted-by":"crossref","first-page":"H1031","DOI":"10.1152\/ajpheart.00105.2002","article-title":"Transmural action potential and ionic current remodeling in ventricles of failing canine hearts","volume":"283","author":"Li","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib33","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.hrthm.2012.08.027","article-title":"Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review","volume":"9","author":"Marquez","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2019.03.029_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hrthm.2012.09.006","article-title":"Carvedilol analogue inhibits triggered activities evoked by both early and delayed afterdepolarizations","volume":"10","author":"Maruyama","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2019.03.029_bib35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00003495-199345020-00006","article-title":"Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"45","author":"McTavish","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2019.03.029_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2003.05.049","article-title":"Brugada syndrome presenting with sustained monomorphic ventricular tachycardia","volume":"97","author":"Mok","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00210-014-0974-4","article-title":"Carvedilol induces greater control of beta2- than beta 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium","volume":"387","author":"Molenaar","year":"2014","journal-title":"Naunyn Schmiede. Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib38","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1253\/circj.CJ-12-0551","article-title":"KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram","volume":"76","author":"Nakajima","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ejphar.2019.03.029_bib39","doi-asserted-by":"crossref","first-page":"366","DOI":"10.12659\/MSM.883911","article-title":"Effects of carvedilol therapy on cardiac autonomic control, QT dispersion, and ventricular arrhythmias in children with dilated cardiomyopathy","volume":"19","author":"Oflaz","year":"2013","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2019.03.029_bib40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/21678707.2015.1037280","article-title":"Novel therapeutic strategies for the management of ventricular arrhythmias associated with the brugada syndrome","volume":"3","author":"Patocskai","year":"2015","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.ejphar.2019.03.029_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004195","article-title":"Management of brugada syndrome 2016: should all high risk patients receive an ICD? All high-risk patients should receive an implantable cardiac defibrillator","volume":"9","author":"Sieira","year":"2016","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib42","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nrcardio.2016.143","article-title":"Pathogenesis and management of Brugada syndrome","volume":"13","author":"Sieira","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-3565(25)38711-2","article-title":"K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes","volume":"269","author":"Slawsky","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.03.029_bib44","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.hrthm.2013.07.047","article-title":"Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome","volume":"10","author":"Szel","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2019.03.029_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/XV.2000.5494","article-title":"The inhibitory effects of carvedilol against arrhythmias induced by coronary reperfusion in anesthetized rats","volume":"5","author":"Takusagawa","year":"2000","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.03.029_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2012.09.020","article-title":"Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation","volume":"111","author":"Ulimoen","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib47","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2013.02.077","article-title":"Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries","volume":"61","author":"Viskin","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2019.03.029_bib48","doi-asserted-by":"crossref","first-page":"e57864","DOI":"10.1371\/journal.pone.0057864","article-title":"Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.03.029_bib49","doi-asserted-by":"crossref","first-page":"e51550","DOI":"10.1371\/journal.pone.0051550","article-title":"Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells","volume":"7","author":"Xu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2019.03.029_bib50","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.CIR.100.15.1660","article-title":"Cellular basis for the brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation","volume":"100","author":"Yan","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2019.03.029_bib51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/ALN.0000000000000495","article-title":"Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels","volume":"122","author":"Yang","year":"2015","journal-title":"Anesthesiology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919301839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:06:29Z","timestamp":1762142789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919301839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":51,"alternative-id":["S0014299919301839"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.029","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}